中進醫療：三號廠房正式投產 滁州智能製造基地加速全球交付

中國北京，2025年7月16日 —— 納斯達克上市公司中進醫療（Nasdaq: ZJYL，「中進醫療」，連同其全資子公司統稱「公司」）今日宣佈，其全資子公司中進醫療器械（安徽）有限公司（「中進安徽」）位於中國安徽滁州的智能製造基地三號廠房正式啟動投產。中進醫療深耕康復科技19載，依託強大的產能保障與精密製造能力，致力於加快全球康復器械供應鏈的一體化進程。

走進滁州智能製造基地，機械臂在恆温車間精準作業，鋁合金骨架在激光焊接中迸射湛藍星火。這座年產20萬台的「智造引擎」正將JIS認證的品質，深深鐫刻進每一道焊縫，為中進醫療不斷擴展的跨地區市場提供堅實支撐。

公司不斷拓展康復器械產品生態，打通康復與大健康多領域應用。產品涵蓋5.5公斤超輕型輪椅、經國際殘奧委員會認證的競賽級設備、聚焦健康與養生的微型高壓氧艙，以及延伸至生活美學領域的美容健康產品。公司秉持跨學科創新驅動戰略，精準洞察各區域多元化的健康需求，具備前瞻性的技術開發與市場響應能力。

"我們正見證康復科技從功能保障向品質生活升級的歷史性轉變，"董事長兼首席執行官王爾琪博士強調，"當中國的智能製造對接全球的健康需求洞察，真正以人為本的健康解決方案便應運而生。"

此刻，最新下線的電動輪椅正在通過嚴苛的震動測試，它們即將啟程前往伊斯坦布爾的養老社區、耶路撒冷的康復中心、東京的家庭診所，我們力求用科技的力量彌合地域的鴻溝。

在這條貫通東西的康復科技新絲路上，中進醫療的全球敍事纔剛剛起筆。

About Jin Medical International Ltd.

Founded in 2006 and headquartered at Changzhou, Jiangsu Province of China, Jin Medical designs, develops, manufactures and markets wheelchairs and living aids products for people with disabilities, elderlies, and for rehabilitation application. Currently, Jin Medical already operates two manufacturing plants of approximately 230,000 square feet in the aggregate in Changzhou City and Taizhou City, Jiangsu Province, China. Jin Medical is currently establishing a new facility with 430,000 square feet in Chuzhou, Anhui Province, China. Jin Medical works with more than 40 distributors in China and more than 20 international distributors. The majority of Jin Medical’s wheelchair products, with more than 30 models, are sold to distributors in Japan and China. Jin Medical continuously delivers innovative wheelchair products that are both lightweight and ergonomic.

Forward-Looking Statement

This press release contains forward-looking statements as defined by the Private Securities Litigation Reform Act of 1995. Forward-looking statements include statements concerning plans, objectives, goals, strategies, future events or performances, and underlying assumptions and other statements that are other than statements of historical facts. When the Company uses words such as 「may,」 「will,」 「should,」 「intend,」 「plan,」 「strive,」 「believe,」 「expect,」 「anticipate,」 「project,」 「estimate」 or similar expressions that do not relate solely to historical matters, it is making forward-looking statements. Forward-looking statements are not guarantees of future performance and involve risks and uncertainties that may cause the actual results to differ materially from the Company’s expectations discussed in the forward-looking statements. These statements are subject to uncertainties and risks, including, but not limited to, the following: the Company’s ability to achieve its goals and strategies, the Company’s future business development and plans for future business development, including its financial conditions and results of operations, product and service demand and acceptance, reputation and brand, the impact of competition and pricing, changes in technology, government regulations, import and export restrictions, fluctuations in general economic and business conditions, and assumptions underlying or related to any of the foregoing and other risks contained in reports filed by the Company with the U.S. Securities and Exchange Commission (「SEC」). For these reasons, among others, investors are cautioned not to place undue reliance upon any forward-looking statements in this press release. Additional factors are discussed in the Company’s filings with the SEC, as well as its current reports on Form 6-K and other filings, all of which are available for review at www.sec.gov. The Company undertakes no obligation to publicly revise these forward-looking statements to reflect events or circumstances that arise after the date hereof.

Reviewed and approved for release

By:

編輯：侯宜均